 |
Susan M. Poutanen, MD, MPH, FRCPC
Microbiologist & Infectious Disease Consultant
University Health Network & Mount Sinai Hospital
Department of Microbiology
600 University Avenue, Room 1470
Toronto, ON Canada M5G 1X5
Phone: (416) 586-3139
Fax: (416) 586-8746
Email: spoutanen@mtsinai.on.ca |
Biography
Dr. Poutanen is certified in Internal Medicine, Infectious
Diseases, and Medical Microbiology by the Royal College of Physicians
and Surgeons of Canada and certified in Internal Medicine and
Infectious Diseases by the American Board of Internal Medicine.
She received her Medical Degree from the University of Toronto
and completed Internal Medicine and Medical Microbiology Residencies
at the University of Toronto. She trained in Infectious Diseases
at Stanford University, California and received her Masters of
Public Health from the University of California, Berkeley.
Dr. Poutanen is working as a Microbiologist and Infectious
Disease Consultant at the University Health Network & Mount
Sinai Hospital Department of Microbiology. She is an assistant
professor in the Department of Laboratory Medicine and Pathobiology
at the University of Toronto. Her responsibilities are shared
between clinical service, teaching, and research. Her broad research
interests include the epidemiology and prevention of antimicrobial
resistance and the diagnosis of and preparedness for emerging
infectious diseases such as Severe Acute Respiratory Syndrome
(SARS).
Recent Publications
- Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, Willey BM, Devries ME, Fang Y, Seneviratne C, Bosinger SE, Persad D, Wilkinson P, Greller LD, Somogyi R, Humar A, Keshavjee S, Louie M, Loeb MB, Brunton J, McGeer AJ, Kelvin DJ
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in severe acute respiratory syndrome (SARS) patients
J Virol Methods Epub ahead of print, 5/30/2007.
- Poutanen SM
Do your biohazard, bioterror, and emergency planning NOW
MLO 39(2):38, 40-1, 2/1/2007.
- Srinivasan S, McAllum P, Poutanen SM, Slomovic AR
Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty
J Virol Methods 32(12):2149-52, 12/1/2006.
- Boggild AK, Poutanen SM, Mohan S, Ostrowski MA
Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection
Med Mycology 44(8):777-82, 12/1/2006.
- Louie L, Simor AE, Chong S, Luinstra K, Petrich A, Mahony J, Smieja M, Johnson G, Gharabaghi F, Tellier R, Willey BM, Poutanen S, Mazzulli T, Broukhanski G, Jamieson F, Louie M, Richardson S; Ontario Laboratory Working Group for the Rapid Diagnosis of Emerging Pathogens
Detection of severe acute respiratory syndrome coronavirus in stool specimens by commercially available real-time reverse transcriptase PCR assays
J Clin Microbiol. 44(11):4193-6., 11/1/2006.
- Nicholls JM, Butany J, Poon LL, Chan KH, Beh SL, Poutanen S, Peiris JS, Wong M.
Time Course and Cellular Localization of SARS-CoV Nucleoprotein and RNA in Lungs from Fatal Cases of SARS.
PLoS Med. 3(2):e27, 1/3/2006.
- Drews SJ, Poutanen SM, Mazzulli T, McGeer AJ, Sarabia A, Pong-Porter S, Rzayev Y, Willey B, Green K, Low DE.
Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.
J Clin Microbiol. 43(8):4218-4220., 8/1/2005.
- Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P.
Treatment and vaccines for severe acute respiratory syndrome.
Lancet Infect Dis. 5(3):147-155., 3/1/2005.
- Poutanen SM, Vearncombe M, McGeer AJ, Gardam M, Large G, Simor AE.
Nosocomial acquisition of methicillin-resistant Staphylococcus aureus during an outbreak of severe acute respiratory syndrome.
Inf Con & Hosp Epid. 26(2):134-137., 2/1/2005.
- Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, Kain KC.
Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus.
J Infect Dis. 191(2):193-197., 1/15/2005.
This website has been made possible through an unrestricted educational grant from
Pfizer Canada Inc. |
|
